PortfoliosLab logo

Amylyx Pharmaceuticals, Inc. (AMLX)

Equity · Currency in USD · Last updated Dec 8, 2022

Company Info

ISINUS03237H1014
CUSIP03237H101
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$37.52
EMA (50)$34.54
EMA (200)$25.03
Average Volume$1.09M
Market Capitalization$2.49B

AMLXShare Price Chart


Loading data...

AMLXPerformance

The chart shows the growth of $10,000 invested in Amylyx Pharmaceuticals, Inc. in Jan 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $19,747 for a total return of roughly 97.47%. All prices are adjusted for splits and dividends.


0.00%50.00%100.00%150.00%200.00%JulyAugustSeptemberOctoberNovemberDecember
177.31%
0.84%
AMLX (Amylyx Pharmaceuticals, Inc.)
Benchmark (^GSPC)

AMLXCompare to other instruments

Search for stocks, ETFs, and funds to compare with AMLX

AMLXReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M9.16%4.33%
6M212.41%-5.45%
YTD97.47%-16.23%
1Y97.47%-16.23%
5YN/AN/A
10YN/AN/A

AMLXMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
202222.00%41.93%-60.94%-29.96%-1.22%116.65%40.13%-6.48%11.53%26.71%7.57%-2.22%

AMLXSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The chart below displays rolling 12-month Sharpe Ratio.


Chart placeholderNot enough data

AMLXDividend History


Amylyx Pharmaceuticals, Inc. doesn't pay dividends

AMLXDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-60.00%-40.00%-20.00%0.00%FebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember
-4.43%
-16.77%
AMLX (Amylyx Pharmaceuticals, Inc.)
Benchmark (^GSPC)

AMLXWorst Drawdowns

The table below shows the maximum drawdowns of the Amylyx Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Amylyx Pharmaceuticals, Inc. is 79.18%, recorded on May 11, 2022. It took 104 trading sessions for the portfolio to recover.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-79.18%Mar 1, 202251May 11, 2022104Oct 10, 2022155
-17.59%Feb 2, 20228Feb 11, 20225Feb 18, 202213
-13.39%Oct 27, 20228Nov 7, 202213Nov 25, 202221
-12.97%Jan 20, 20222Jan 21, 20226Jan 31, 20228
-12%Jan 7, 20222Jan 10, 20221Jan 11, 20223
-7.9%Jan 14, 20222Jan 18, 20221Jan 19, 20223
-5.42%Nov 28, 20221Nov 28, 20223Dec 1, 20224
-5.27%Dec 2, 20223Dec 6, 2022
-3.44%Feb 23, 20221Feb 23, 20221Feb 24, 20222
-3.19%Oct 11, 20221Oct 11, 20222Oct 13, 20223

AMLXVolatility Chart

Current Amylyx Pharmaceuticals, Inc. volatility is 49.18%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%200.00%250.00%300.00%JulyAugustSeptemberOctoberNovemberDecember
49.18%
22.83%
AMLX (Amylyx Pharmaceuticals, Inc.)
Benchmark (^GSPC)